ArticleiScience2026

Genomic biomarkers of immunotherapy plus chemotherapy in patients with advanced NSCLC: Insights from the phase 3 ORIENT-11 study.

Jun Liao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.